Foley Hoag’s highly trained, respected, and experienced patent prosecution professionals can meet your legal needs at many levels. We believe that strategic counsel for developing and managing intellectual property is essential to your ability to succeed in an increasingly sophisticated and competitive marketplace. And our clients’ success is our ultimate goal.
learn more
-
Foley Hoag Launches New Microsite for Law Students as 2009 On-campus Interviews Commence
[Read More]
-
Working Mother and Flex-Time Lawyers Recognize Foley Hoag
[Read More]
-
Global Bio-Chem Technology Group Company Limited, Foley Hoag LLP, and Adduci, Mastriani & Schaumberg LLP Prevail in International Trade Commission Patent Infringement Investigation
[Read More]
-
Foley Hoag Joins American Lawyer's Select Group of Top 50 A-List Firms
[Read More]
-
Foley Hoag Files Amicus Brief for Biotechnology Industry Organization
[Read More]
Publications more
- Failure to Obtain Opinion of Counsel May Be Evidence of Intent to Induce Infringement [Read More]
- EEC Perspectives - September 2008 [Read More]
- Hatch-Waxman Safe Harbor Inapplicable to Research Tools [Read More]
- Foley Hoag Secures ITC Victory [Read More]
- Medicare Datasheet [Read More]
| October 19, 2008 |
ACC Annual Meeting '08 [Read More] |
Washington State Convention & Trade Center Seattle, WA |
| October 22, 2008 |
Looking Into The Crystal Ball - How To Prosecute Patents Today That Will Be Enforceable For Twenty Years? [Read More] |
The Conference Center at WilmerHale Boston, MA |
| November 6, 2008 |
TCN: Funding Expedition™ Mixer [Read More] |
Foley Hoag LLP (Boston Office) Boston, MA |
| November 12, 2008 |
American Conference Institute’s 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements: Allocating Rights, Responsibilities & Rewards in Licensing, Strategic Alliances and Partnering Deals [Read More] |
Helmsley Park Lane Hotel New York, NY |
Client Successes more
-
Driving Biopharma Forward
Our lawyers identified, on the eve of FDA approval of one of our client's biopharmaceuticals, a prior public use that would cause a court to invalidate the otherwise blocking patent claims. This enabled our client to negotiate a license under the patent on commercially reasonable terms. [Read More]
-
Due Diligence Across the World
We were retained by one of the world's largest pharmaceutical companies to join a team of in-house management-level scientific and business decision-makers on an IP due-diligence trip to eastern Europe. The team vetted the potential licensor's patent and trade-secret portfolios, and also considered potential associated regulatory and logistical issues. [Read More]
Attorney advertising. Prior results do not guarantee a similar outcome. Copyright © 2008 Foley Hoag LLP. All rights reserved.